Lonza, a major CDMO, is to invest $518 million in a new, massive fill-finish manufacturing facility in Stein, Switzerland. According to the firm, the facility will use sustainable construction methods to lower carbon emissions when it is finished in 2026. According to Lonza, the project would symbolise the achievement of the company’s ambition to provide […]

The post Switzerland To Get A 8mn Fill-Finish Plant From Lonza first appeared on World Pharma Today.